Neven A K, Middelkoop H A, Kemp B, Kamphuisen H A, Springer M P
Department of General Practice, Leiden University Medical Centre, The Netherlands.
Thorax. 1998 Aug;53(8):638-42. doi: 10.1136/thx.53.8.638.
Figures for the prevalence of sleep apnoea syndrome range from 0.3% to 8.5%. These widely ranged estimates are probably due to differences in the definitions used, study designs, and study populations. A study was undertaken to determine the lower limit of the prevalence of clinically significant sleep apnoea syndrome.
A cross sectional survey by postal questionnaire was carried out in a general practice of a small town in which three doctors serve 93% of its population of 6747 inhabitants of all ages. All men aged 35 and over and women aged 50 and over were invited to fill in a specially designed questionnaire on snoring and sleep. All men and women whose answers suggested the possible occurrence of sleep apnoea were invited to undergo further investigation. Oronasal thermistry was performed in the subjects' homes and the results were scored to provide an apnoea index (AI). Those subjects with an AI of > or = 5 were referred to a sleep laboratory for investigation by polysomnography.
Of the 2466 questionnaires issued, 2182 (88.5%) were completed and returned. The occurrence during the previous three months of regular snoring, together with daytime sleepiness and/or partners' observation of interruptions in breathing at night, was reported by 194 subjects (169 men, 25 women). In 173 subjects oronasal thermistry applied in their homes provided satisfactory recordings and, of these, 24 men and one woman had an AI of > or = 5. Analysis of the polysomnographic findings showed that 14 men and one woman met the criteria for sleep apnoea syndrome. Scrutiny of their case records disclosed that in seven men this was clinically significant.
Our findings suggest that the prevalence of clinically significant sleep apnoea syndrome in men aged 35 and over is at least 0.45%. Extrapolation to the population of the Netherlands suggests that at least 16,000 men suffer from sleep apnoea syndrome that should be relieved by medical care. A large proportion of these subjects remains to be diagnosed.
睡眠呼吸暂停综合征的患病率数据在0.3%至8.5%之间。这些差异巨大的估计值可能是由于所采用的定义、研究设计和研究人群的不同。开展了一项研究以确定具有临床意义的睡眠呼吸暂停综合征患病率的下限。
通过邮政问卷在一个小镇的全科医疗中心进行了一项横断面调查,该小镇有三名医生为全镇6747名各年龄段居民中的93%提供服务。邀请所有35岁及以上男性和50岁及以上女性填写一份专门设计的关于打鼾和睡眠的问卷。所有回答提示可能发生睡眠呼吸暂停的男性和女性均被邀请接受进一步检查。在受试者家中进行口鼻温度测定,并对结果进行评分以得出呼吸暂停指数(AI)。AI≥5的受试者被转至睡眠实验室进行多导睡眠图检查。
在发放的2466份问卷中,2182份(88.5%)被填写并返回。194名受试者(169名男性,25名女性)报告在前三个月有规律打鼾,同时伴有日间嗜睡和/或伴侣观察到夜间呼吸中断。173名受试者在家中进行的口鼻温度测定获得了满意的记录,其中24名男性和1名女性的AI≥5。多导睡眠图检查结果分析显示,14名男性和1名女性符合睡眠呼吸暂停综合征的标准。仔细查阅他们的病历发现,7名男性的病情具有临床意义。
我们的研究结果表明,35岁及以上男性中具有临床意义的睡眠呼吸暂停综合征患病率至少为0.45%。推算至荷兰人口,表明至少有16000名男性患有睡眠呼吸暂停综合征,需要医疗护理来缓解。这些受试者中很大一部分仍有待诊断。